Guido J Neels bought $21k of ELUT
director at AZIYO BIOLOGICS, INC.. 20,000 shares at an average of $1.04, traded Jan 30, 2026, filed Feb 2, 2026.
Score components
- +15RoleDirector
- 0Trade size$21k at market
- +6Relative to holdingsHoldings up 20%
- +8Price context68% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +16.7%, 3m -1.0%, 6m -15.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001222362-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | POpen-market purchase Class A Common Stock | +20,000 | $1.04 | $21k | 118,750 | Feb 2, 2026 |
Related signals
Other insiders at AZIYO BIOLOGICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 54Moderate | AZIYO BIOLOGICS, INC. | Kevin Rakin director, owner | $74k 70,000 shares | +56% | |
| 42Moderate | AZIYO BIOLOGICS, INC. | Guido J Neels director | $32k 30,000 shares | +44% | |
| 56Moderate | AZIYO BIOLOGICS, INC. | Kevin Rakin director, owner | $26k 50,000 shares | +18% | |
| 63Notable | AZIYO BIOLOGICS, INC. | David Colpman director | $6,375 12,500 shares | +67% | |
| 68Notable | AZIYO BIOLOGICS, INC. | Matthew Ferguson CHIEF FINANCIAL OFFICER | $32k 60,000 shares | +15% | |
| 58Moderate | AZIYO BIOLOGICS, INC. | C Randal Mills PRESIDENT AND CEO | $1,530 3,000 shares | +1% | |
| 58Moderate | AZIYO BIOLOGICS, INC. | Brigid Makes director | $13k 25,000 shares | +1250% | |
| 45Moderate | AZIYO BIOLOGICS, INC. | Matthew Ferguson CHIEF FINANCIAL OFFICER | $6,610 10,000 shares | +3% | |
| 63Notable | AZIYO BIOLOGICS, INC. | C Randal Mills PRESIDENT AND CEO | $3,000 5,000 shares | +1% | |
| 58Moderate | AZIYO BIOLOGICS, INC. | David Colpman director | $11k 15,500 shares | +500% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.